Heather E. Cunliffe

1.5k total citations
28 papers, 1.2k citations indexed

About

Heather E. Cunliffe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Heather E. Cunliffe has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Heather E. Cunliffe's work include Estrogen and related hormone effects (8 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Heather E. Cunliffe is often cited by papers focused on Estrogen and related hormone effects (8 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Heather E. Cunliffe collaborates with scholars based in United States, New Zealand and Germany. Heather E. Cunliffe's co-authors include Barbara A. Pockaj, Ann E. McCullough, Amanda L. Willis, Paul S. Meltzer, Helen R. Kim, Joan Lewis-Wambi, Michael T. Barrett, V. Craig Jordan, Amylou C. Dueck and Pilar Ramos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Heather E. Cunliffe

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather E. Cunliffe United States 19 599 497 367 323 179 28 1.2k
Christina W. Yde Denmark 22 655 1.1× 458 0.9× 323 0.9× 223 0.7× 188 1.1× 59 1.2k
Wan-Ching Yen United States 17 912 1.5× 590 1.2× 232 0.6× 129 0.4× 99 0.6× 47 1.3k
Dhivya R. Sudhan United States 13 639 1.1× 505 1.0× 416 1.1× 147 0.5× 341 1.9× 28 1.2k
Ángel Guerrero‐Zotano Spain 12 735 1.2× 454 0.9× 445 1.2× 94 0.3× 188 1.1× 29 1.1k
Kideok Jin United States 20 864 1.4× 580 1.2× 310 0.8× 121 0.4× 129 0.7× 28 1.3k
Pascal Drané France 17 1.4k 2.3× 464 0.9× 211 0.6× 176 0.5× 109 0.6× 24 1.7k
Letícia Batista Azevedo Rangel Brazil 14 568 0.9× 284 0.6× 280 0.8× 111 0.3× 106 0.6× 39 1.1k
Ylenia Lombardo United Kingdom 18 815 1.4× 702 1.4× 459 1.3× 107 0.3× 120 0.7× 20 1.4k
Xiao-Feng Le United States 21 910 1.5× 462 0.9× 274 0.7× 105 0.3× 92 0.5× 23 1.3k
Gretchen M. Unger United States 17 1.2k 2.0× 438 0.9× 181 0.5× 144 0.4× 83 0.5× 29 1.6k

Countries citing papers authored by Heather E. Cunliffe

Since Specialization
Citations

This map shows the geographic impact of Heather E. Cunliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather E. Cunliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather E. Cunliffe more than expected).

Fields of papers citing papers by Heather E. Cunliffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather E. Cunliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather E. Cunliffe. The network helps show where Heather E. Cunliffe may publish in the future.

Co-authorship network of co-authors of Heather E. Cunliffe

This figure shows the co-authorship network connecting the top 25 collaborators of Heather E. Cunliffe. A scholar is included among the top collaborators of Heather E. Cunliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather E. Cunliffe. Heather E. Cunliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kee, Damien, Susie Bae, Katherine Tucker, et al.. (2020). CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research. JCO Clinical Cancer Informatics. 4(4). 136–146.
2.
Cunliffe, Heather E., et al.. (2019). Long Non-coding RNA ANRIL in the Nucleus Associates With Periostin Expression in Breast Cancer. Frontiers in Oncology. 9. 885–885. 15 indexed citations
3.
Mehta, Sunali, Brianna C. Morten, Jisha Antony, et al.. (2018). Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes. Oncotarget. 9(49). 29146–29161. 15 indexed citations
4.
Hoppe, Reiner, Ping Fan, Florian Büttner, et al.. (2016). Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer. Oncotarget. 7(44). 71235–71254. 13 indexed citations
5.
Necela, Brian M., Jennifer A. Crozier, Cathy Andorfer, et al.. (2015). Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors. PLoS ONE. 10(3). e0122209–e0122209. 117 indexed citations
6.
Suman, Vera J., Malayannan Subramaniam, Xianglin Wu, et al.. (2014). ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer. BMC Cancer. 14(1). 749–749. 54 indexed citations
7.
Fan, Ping, et al.. (2014). A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer. European Journal of Cancer. 50(16). 2866–2876. 41 indexed citations
8.
McGhan, Lee J., Ann E. McCullough, Cheryl Protheroe, et al.. (2013). Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype. Annals of Surgical Oncology. 21(2). 361–367. 125 indexed citations
9.
Asmann, Yan W., Brian M. Necela, Krishna R. Kalari, et al.. (2012). Detection of Redundant Fusion Transcripts as Biomarkers or Disease-Specific Therapeutic Targets in Breast Cancer. Cancer Research. 72(8). 1921–1928. 75 indexed citations
10.
Holley, Tara, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples. PLoS ONE. 7(11). e50586–e50586. 38 indexed citations
11.
Kimbung, Siker, Ida Johansson, Kristina Aaltonen, et al.. (2012). Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition. Cancer Letters. 319(2). 232–241. 37 indexed citations
12.
Cunliffe, Heather E., Yuan Jiang, Kimberly Fornace, Fan Yang, & Paul S. Meltzer. (2012). PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer.. PubMed. 2(5). 478–91. 27 indexed citations
13.
Jordan, V. Craig, Ifeyinwa E. Obiorah, Ping Fan, et al.. (2011). The St. Gallen Prize Lecture 2011: Evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities. The Breast. 20. S1–S11. 29 indexed citations
14.
Rennstam, Karin, Anita Ringberg, Heather E. Cunliffe, et al.. (2009). Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency. Genes Chromosomes and Cancer. 49(1). 78–90. 19 indexed citations
15.
Willis, Amanda L., Nhan L. Tran, Nichole Charlton, et al.. (2008). The Fibroblast Growth Factor–Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity. Molecular Cancer Research. 6(5). 725–734. 73 indexed citations
16.
Lewis-Wambi, Joan, Heather E. Cunliffe, Helen R. Kim, Amanda L. Willis, & V. Craig Jordan. (2008). Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells. European Journal of Cancer. 44(12). 1770–1779. 60 indexed citations
17.
Jordan, V. Craig, Joan Lewis-Wambi, Helen Kim, et al.. (2007). Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients. The Breast. 16. 105–113. 21 indexed citations
18.
Denton, M., et al.. (2007). 63 Use of tigecycline to treat difficult respiratory pathogens in cystic fibrosis – early experiences. Journal of Cystic Fibrosis. 6. S15–S15. 1 indexed citations
19.
Azorsa, David O., Heather E. Cunliffe, & Paul S. Meltzer. (2001). Association of steroid receptor coactivator AIB1 with estrogen receptor-α in breast cancer cells. Breast Cancer Research and Treatment. 70(2). 89–101. 26 indexed citations
20.
Scherr, Michaela, Jeanne M. LeBon, Daniela Castanotto, et al.. (2001). Detection of Antisense and Ribozyme Accessible Sites on Native mRNAs: Application to NCOA3 mRNA. Molecular Therapy. 4(5). 454–460. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina W. Yde Breakdown of academic impact, for papers by Wan-Ching Yen Breakdown of academic impact, for papers by Dhivya R. Sudhan Breakdown of academic impact, for papers by Ángel Guerrero‐Zotano Breakdown of academic impact, for papers by Kideok Jin Breakdown of academic impact, for papers by Pascal Drané Breakdown of academic impact, for papers by Letícia Batista Azevedo Rangel Breakdown of academic impact, for papers by Ylenia Lombardo Breakdown of academic impact, for papers by Xiao-Feng Le Breakdown of academic impact, for papers by Gretchen M. Unger
Rankless by CCL
2026